Interobserver concordance in visual assessment of Ki67 immunohistochemistry in surgical excision specimens from patients with lymph node-negative breast cancer

被引:1
作者
Thomas, Susanna [1 ,2 ,3 ]
Kabir, Masrura [1 ,2 ]
Butcher, Belinda E. [4 ,5 ]
Chou, Shaun [6 ]
Mahajan, Hema [6 ,7 ]
Farshid, Gelareh [8 ,9 ]
Balleine, Rosemary [6 ,10 ]
Pathmanathan, Nirmala [1 ,2 ,7 ,11 ]
机构
[1] Westmead Breast Canc Inst, Westmead, NSW 2145, Australia
[2] Western Sydney Local Hlth Dist, Westmead, NSW 2145, Australia
[3] Australian Clin Labs, Bella Vista, NSW 2153, Australia
[4] WriteSource Med Pty Ltd, Lane Cove, NSW 2066, Australia
[5] Univ New South Wales, Sch Med Sci, Sydney, NSW 2052, Australia
[6] NSW Hlth Pathol, Inst Clin Pathol & Med Res, Pathol West, Sydney, NSW 2145, Australia
[7] Univ Sydney, Westmead Clin Sch, Sydney, NSW 2145, Australia
[8] Royal Adelaide Hosp, SA Pathol, Adelaide, SA 5000, Australia
[9] Univ Adelaide, Sch Med Sci, Adelaide, SA 5005, Australia
[10] Univ Sydney, Childrens Med Res Inst, Fac Med & Hlth, Westmead, NSW 2145, Australia
[11] Douglass Hanly Moir Pathol, Macquarie Pk, NSW 2113, Australia
关键词
Ki67; Proliferation; Breast cancer; Interobserver variability;
D O I
10.1007/s10549-021-06188-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose This study aimed to determine the interobserver concordance of two methods for proliferation assessment in breast cancer using Ki67 immunohistochemistry. Methods Ki67 was independently assessed in randomly selected tumour samples from patients with lymph node-negative breast cancer using two different methods: either cell counting or visual estimation of hot spot areas. For hot spot cell counting, positive and negative cell numbers were recorded for total cell counts of 300-500, 500-800 and 800-1000 cells. Visual estimation involved allocation of a score from 1 to 5 using a visual scale to estimate percentage positivity. Interobserver agreement for hot spot counting was calculated using a two-way fixed effects intraclass correlation model, and by using Cohen's kappa measure for visual assessment. Prognostic concordance between the two methods was also calculated using Cohen's kappa. Results Samples from 96 patients were included in this analysis. Interobserver agreement for hot spot cell counting was excellent (> 0.75) across all three cell count ranges, with correlation coefficients of 0.88 (95% CI 0.84-0.92), 0.87 (95% CI 0.82-0.91) and 0.89 (95% CI 0.85-0.92), respectively. Interobserver agreement with visual estimation was greatest for hot spots compared with areas of intermediate or low proliferation, with kappa scores of 0.49, 0.42 and 0.40, respectively. Both assessment methods demonstrated excellent prognostic agreement. Conclusions Interobserver and prognostic concordance in Ki67 immunohistochemistry assessments was high using either hot spot cell counting or visual estimation, further supporting the utility and reproducibility of these cost-efficient methods to assess proliferation.
引用
收藏
页码:729 / 737
页数:9
相关论文
共 28 条
[1]  
Abraira V., 1999, QUESTIIO, V23, P561
[2]   High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium [J].
Abubakar, Mustapha ;
Howat, William J. ;
Daley, Frances ;
Zabaglo, Lila ;
McDuffus, Leigh-Anne ;
Blows, Fiona ;
Coulson, Penny ;
Ali, H. Raza ;
Benitez, Javier ;
Milne, Roger ;
Brenner, Herman ;
Stegmaier, Christa ;
Mannermaa, Arto ;
Chang-Claude, Jenny ;
Rudolph, Anja ;
Sinn, Peter ;
Couch, Fergus J. ;
Tollenaar, Rob A. E. M. ;
Devilee, Peter ;
Figueroa, Jonine ;
Sherman, Mark E. ;
Lissowska, Jolanta ;
Hewitt, Stephen ;
Eccles, Diana ;
Hooning, Maartje J. ;
Hollestelle, Antoinette ;
Martens, John W. M. ;
van Deurzen, Carolien H. M. ;
Bolla, Manjeet K. ;
Wang, Qin ;
Jones, Michael ;
Schoemaker, Minouk ;
Broeks, Annegien ;
van Leeuwen, Flora E. ;
Van't Veer, Laura ;
Swerdlow, Anthony J. ;
Orr, Nick ;
Dowsett, Mitch ;
Easton, Douglas ;
Schmidt, Marjanka K. ;
Pharoah, Paul D. ;
Garcia-Closas, Montserrat .
JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2016, 2 (03) :138-153
[3]   A risk index for early node-negative breast cancer [J].
Boyages, J. ;
Taylor, R. ;
Chua, B. ;
Ung, O. ;
Bilous, M. ;
Salisbury, E. ;
Wilcken, N. .
BRITISH JOURNAL OF SURGERY, 2006, 93 (05) :564-571
[4]   Estimating receiver operative characteristic curves for time-dependent outcomes: The stroccurve package [J].
Cattaneo, Mattia ;
Malighetti, Paolo ;
Spinelli, Daniele .
STATA JOURNAL, 2017, 17 (04) :1015-1023
[5]  
Cicchetti D. V., 1994, Psychological Assessment, V6, P284, DOI [DOI 10.1037/1040-3590.6.4.284, 10.1037/1040-3590.6.4.284]
[6]   Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients [J].
de Azambuja, E. ;
Cardoso, F. ;
de Castro, G., Jr. ;
Colozza, M. ;
Mano, M. S. ;
Durbecq, V. ;
Sotiriou, C. ;
Larsimont, D. ;
Piccart-Gebhart, M. J. ;
Paesmans, M. .
BRITISH JOURNAL OF CANCER, 2007, 96 (10) :1504-1513
[7]   Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group [J].
Dowsett, Mitch ;
Nielsen, Torsten O. ;
A'Hern, Roger ;
Bartlett, John ;
Coombes, R. Charles ;
Cuzick, Jack ;
Ellis, Matthew ;
Henry, N. Lynn ;
Hugh, Judith C. ;
Lively, Tracy ;
McShane, Lisa ;
Paik, Soon ;
Penault-Llorca, Frederique ;
Prudkin, Ljudmila ;
Regan, Meredith ;
Salter, Janine ;
Sotiriou, Christos ;
Smith, Ian E. ;
Viale, Giuseppe ;
Zujewski, Jo Anne ;
Hayes, Daniel F. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (22) :1656-1664
[8]  
Elston C W, 2002, Histopathology, V41, P151
[9]   Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment [J].
Fasching, Peter A. ;
Heusinger, Katharina ;
Haeberle, Lothar ;
Niklos, Melitta ;
Hein, Alexander ;
Bayer, Christian M. ;
Rauh, Claudia ;
Schulz-Wendtland, Ruediger ;
Bani, Mayada R. ;
Schrauder, Michael ;
Kahmann, Laura ;
Lux, Michael P. ;
Strehl, Johanna D. ;
Hartmann, Arndt ;
Dimmler, Arno ;
Beckmann, Matthias W. ;
Wachter, David L. .
BMC CANCER, 2011, 11
[10]   Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 [J].
Goldhirsch, A. ;
Winer, E. P. ;
Coates, A. S. ;
Gelber, R. D. ;
Piccart-Gebhart, M. ;
Thuerlimann, B. ;
Senn, H. -J. .
ANNALS OF ONCOLOGY, 2013, 24 (09) :2206-2223